Q2 2026 Holdings
Filed 2026-08-14 | 35 holdings | $398.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $45.3M | 1,170,740 | 11.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $40.6M | 1,855,000 | 10.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $36.8M | 990,000 | 9.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $27.4M | 1,465,279 | 6.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $26.3M | 452,340 | 6.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $18.7M | 436,518 | 4.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $18.2M | 525,750 | 4.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $18.1M | 984,931 | 4.5% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $17.1M | 4,550,000 | 4.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $16.6M | 292,600 | 4.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $16.5M | 570,569 | 4.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $16.3M | 476,338 | 4.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $12.6M | 690,000 | 3.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $11.2M | 460,000 | 2.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $8.2M | 22,000 | 2.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $8.1M | 15,000 | 2.0% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $7.2M | 493,820 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.9M | 65,000 | 1.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.2M | 520,000 | 1.3% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $5.0M | 91,000 | 1.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.7M | 38,000 | 1.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.4M | 120,000 | 1.1% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $4.3M | 265,000 | 1.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $3.7M | 130,000 | 0.9% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $3.3M | 70,000 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.7M | 47,000 | 0.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $2.6M | 81,143 | 0.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.0M | 112,000 | 0.5% |
| Alector Inc(ALEC) | COM | 014442107 | $1.8M | 900,000 | 0.5% |
| Septerna Inc(SEPN) | COM | 81734D104 | $1.7M | 49,444 | 0.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $1.6M | 107,900 | 0.4% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $1.1M | 32,037 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.0M | 177,846 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $638.8K | 20,000 | 0.2% |
| Engene Therapeutics Inc(ENGN) | COM | 29286X101 | $363.3K | 210,000 | 0.1% |